Outlook | Published:

Irritable bowel syndrome: 4 big questions

Nature volume 533, page S118 (19 May 2016) | Download Citation

Subjects

There is a long list of unknowns about the causes and symptomatology of irritable bowel syndrome (IBS). But the research challenges can be distilled into four key areas.

Image: Sarah J. Coleman

1. What are the underlying mechanisms of the syndrome?

Why it matters The variety of symptoms and of patient responses to treatment suggest that there are multiple underlying causes of IBS. Identifying specific mechanisms will help researchers to develop better treatments.

What we know The gut can only react to insults in certain ways (for example, diarrhoea, constipation or cramps). But these symptoms could be the end point of several different diseases.

Next steps Researchers have already identified distinct causes of IBS, such as bile-acid malabsorption. Large-scale initiatives such as Europe's GENIEUR consortium are trying to tease out genetic and epigenetic contributions.

2. What is the relationship between the disorder and mental health?

Why it matters For treatment purposes, it is important to know whether IBS starts in the gut and then causes psychological issues, or whether IBS symptoms have a neurological trigger.

What we know Anxiety and depression sometimes accompany IBS. The serotonin system is implicated in the syndrome, and plays a part in neurological conditions. IBS is more common in service personnel who have post-traumatic stress disorder.

Next steps Better grouping of patients by phenotype will help researchers to pick out signals in large-scale trials. In the meantime, clinicians need to be careful not to assume that patients have mainly a psychological problem.

3. How important is diet in driving IBS?

Why it matters Diet seems an obvious starting point for treating IBS. Care will be improved with a better understanding of which subset of patients could benefit from dietary interventions and why.

What we know The fermentation of certain food components by microorganisms in the gut exacerbates symptoms. Diet can ease these, but there is little evidence of a causal link.

Next steps Larger, more rigorous trials will help to isolate the effect of food components. By working closer together, microbiologists, gastroenterologists and nutritionists could improve knowledge of the behaviour of the gut microbiota.

4. Can the syndrome be definitively diagnosed?

Why it matters An IBS diagnosis is based on symptoms and on the elimination of other disorders. This is stressful for patients, frustrating for clinicians and inefficient for the health-care system.

What we know Attempts to develop biomarkers for IBS have been disappointing. Breath tests and diagnostics that involve serum biomarkers are in development, but these have yet to translate to the clinic and many researchers remain sceptical.

Next steps Clearer patient phenotypes will help researchers to identify more specific biomarkers, which can also be used to stratify patients for clinical testing of targeted drugs.

Notes

  1. 1.

    This article is part of the Nature Outlook: IBS

Author information

Affiliations

  1. Michelle Grayson is senior supplements editor at Nature.

    • Michelle Grayson

Authors

  1. Search for Michelle Grayson in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/533S118a

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing